Allink Biotherapeutics Completes $47M Extension Rounds of Series A to Accelerate Clinical Programs and Novel Platforms Development
The company secured $47 million through extension rounds of Series A led by Legend Capital and Meituan Long-Z Investment with strong backing from both new investors and existing supporters Proceeds to advance two differentiated and highly...
DMX-200 ACTION3 PHASE 3 TRIAL COMPLETES RECRUITMENT
Recruitment successfully completed in Dimerix' ACTION3 Phase 3 clinical trial[1], which has recruited and dosed its target 286th adult patient The ACTION3 Phase 3 trial explores the efficacy and safety of DMX-200 in FSGS patients when dosed in...
Exyte completes Pharmaplan integration: A-to-Z execution in GMP facilities
Pharmaplan fully integrated into Exyte, unifying biopharma engineering capabilities under one European organization. Integrated setup drives strong client demand and a record order-intake level in 2025. End-to-end EPC/EPCM delivery from feasibility...
Kinetics Successfully Completes $400 Million Bond Issuance, Strengthening Its Position as a Transparent and Recognized Capital Markets Participant
LONDON, Nov. 6, 2025 /PRNewswire/ -- Kinetics, a Karpowership initiative, has announced the successful completion of a $400 million 4-year senior secured bond issuance, marking an important milestone in its financial strategy and long-term growth....
Samsung Biologics completes spin-off to strengthen its focus as a pure-play CDMO
Spin-off finalized within five months following board resolution Proposal approved in shareholders' meeting with 99.9% support Company to reaffirm its identity as a pure-play CDMO INCHEON, South Korea, Nov. 3, 2025 /PRNewswire/ -- Samsung Biologics...
Novo Tellus completes its transformative growth partnership with Grand Venture Technology
Grand Venture Technology embarks on the next chapter of global growth as Aalberts completes the privatisation of the company SINGAPORE, Oct. 31, 2025 /PRNewswire/ -- Novo Tellus, a leading private equity fund focused on building industrial and...
BioDlink Completes First International Shipment of Bevacizumab to Colombia
Bevacizumab is a targeted therapy used to treat lung and colorectal cancers, both among the top three cancers ranked by death in Colombia[1]. This inaugural shipment—dispatched around two months after Colombia's marketing approval—demonstrates the...
MRI Software Completes Acquisition of Anacle, a leading Singapore-based provider of Property and Facilities Management Solutions
Acquisition extends MRI's footprint in Asia; expands offerings for commercial real estate owners, operators, and tenants; drives scale with AI-powered innovations SYDNEY, June 10, 2025 /PRNewswire/ -- MRI Software, a global leader in real estate...
QureBio Ltd. Completes Nearly CNY 100 Million Series C1 Financing Led by Efung Capital, accelerating clinical progress in global competition for core pipelines
SHANGHAI, June 5, 2025 /PRNewswire/ -- Qure Biotechnology (Shanghai) Co., Ltd. (QureBio) announced that it has completed a Series C1 financing round. The financing raised nearly CNY 100 million (approximately USD 14 million) and was led exclusively...
Innovent Announces a Phase 3 Study of Picankibart (Anti-IL-23p19 Antibody) Completes First Participant Dosing, Exploring Biologics Switching Treatment for Psoriasis Patients with Prior Inadequate Response to Anti-IL-17 Antibodies
SAN FRANCISCO and SUZHOU, China, May 29, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...